Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 24 | 2026 | 980 | 3.500 |
Why?
|
| Huntingtin Protein | 8 | 2026 | 147 | 1.410 |
Why?
|
| Oligonucleotides | 3 | 2026 | 229 | 1.100 |
Why?
|
| Gene Silencing | 10 | 2026 | 430 | 1.080 |
Why?
|
| Acetylgalactosamine | 2 | 2026 | 13 | 1.000 |
Why?
|
| Hyperlipoproteinemia Type I | 1 | 2026 | 3 | 0.960 |
Why?
|
| Apolipoprotein C-III | 1 | 2026 | 7 | 0.960 |
Why?
|
| Central Nervous System | 3 | 2024 | 200 | 0.880 |
Why?
|
| Skin | 1 | 2026 | 419 | 0.750 |
Why?
|
| Huntington Disease | 5 | 2026 | 159 | 0.720 |
Why?
|
| RNA Interference | 6 | 2026 | 643 | 0.490 |
Why?
|
| Animals | 22 | 2026 | 21292 | 0.410 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1629 | 0.390 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 6 | 2026 | 281 | 0.360 |
Why?
|
| RNA, Messenger | 4 | 2026 | 1575 | 0.300 |
Why?
|
| Mice | 15 | 2026 | 11088 | 0.300 |
Why?
|
| Janus Kinase 1 | 2 | 2026 | 17 | 0.290 |
Why?
|
| Gene Knock-In Techniques | 2 | 2026 | 48 | 0.270 |
Why?
|
| Neurons | 3 | 2019 | 933 | 0.270 |
Why?
|
| RNA-Induced Silencing Complex | 2 | 2026 | 72 | 0.260 |
Why?
|
| Prion Proteins | 1 | 2026 | 7 | 0.240 |
Why?
|
| Prion Diseases | 1 | 2026 | 13 | 0.240 |
Why?
|
| Prions | 1 | 2026 | 27 | 0.240 |
Why?
|
| Cholesterol | 2 | 2018 | 261 | 0.240 |
Why?
|
| Injections, Intradermal | 1 | 2026 | 12 | 0.240 |
Why?
|
| Drug Approval | 1 | 2026 | 28 | 0.240 |
Why?
|
| Myostatin | 1 | 2025 | 20 | 0.230 |
Why?
|
| Swine | 1 | 2026 | 394 | 0.220 |
Why?
|
| Hepatocytes | 1 | 2026 | 222 | 0.210 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2023 | 20 | 0.200 |
Why?
|
| Humans | 21 | 2026 | 64958 | 0.200 |
Why?
|
| Myocardium | 1 | 2025 | 301 | 0.200 |
Why?
|
| Nucleic Acids | 1 | 2024 | 66 | 0.200 |
Why?
|
| Organophosphonates | 2 | 2021 | 22 | 0.180 |
Why?
|
| Endocytosis | 2 | 2019 | 152 | 0.170 |
Why?
|
| Vitiligo | 1 | 2023 | 120 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 3469 | 0.170 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 92 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 770 | 0.160 |
Why?
|
| Synaptic Vesicles | 1 | 2019 | 25 | 0.150 |
Why?
|
| Corpus Striatum | 1 | 2019 | 98 | 0.150 |
Why?
|
| Genetic Therapy | 3 | 2021 | 838 | 0.140 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 87 | 0.140 |
Why?
|
| Extracellular Vesicles | 1 | 2018 | 45 | 0.130 |
Why?
|
| Vinyl Compounds | 1 | 2017 | 5 | 0.130 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2018 | 103 | 0.130 |
Why?
|
| Triazoles | 1 | 2017 | 63 | 0.130 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 49 | 0.120 |
Why?
|
| Genome, Human | 1 | 2018 | 237 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2026 | 2281 | 0.120 |
Why?
|
| Guanabenz | 1 | 2015 | 3 | 0.120 |
Why?
|
| Vesicular Transport Proteins | 1 | 2016 | 117 | 0.120 |
Why?
|
| Endosomes | 1 | 2016 | 180 | 0.110 |
Why?
|
| HeLa Cells | 4 | 2018 | 541 | 0.110 |
Why?
|
| Exosomes | 1 | 2016 | 53 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 203 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 333 | 0.110 |
Why?
|
| Gene Editing | 1 | 2018 | 327 | 0.100 |
Why?
|
| Mutation | 2 | 2019 | 2657 | 0.100 |
Why?
|
| Apolipoproteins E | 2 | 2024 | 115 | 0.100 |
Why?
|
| Liver | 3 | 2024 | 868 | 0.090 |
Why?
|
| Alleles | 2 | 2022 | 453 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2018 | 2188 | 0.070 |
Why?
|
| Female | 3 | 2026 | 33929 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2018 | 293 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2025 | 37 | 0.060 |
Why?
|
| Biological Transport | 2 | 2016 | 292 | 0.060 |
Why?
|
| Phosphates | 1 | 2026 | 103 | 0.060 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 38 | 0.060 |
Why?
|
| High-Throughput Screening Assays | 2 | 2015 | 79 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2025 | 76 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2025 | 257 | 0.050 |
Why?
|
| Antagomirs | 1 | 2024 | 5 | 0.050 |
Why?
|
| Brain | 2 | 2026 | 1601 | 0.050 |
Why?
|
| tau Proteins | 1 | 2025 | 210 | 0.050 |
Why?
|
| Heart | 1 | 2025 | 297 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2023 | 112 | 0.050 |
Why?
|
| Gene Expression | 2 | 2016 | 852 | 0.050 |
Why?
|
| Chemical Engineering | 1 | 2022 | 9 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2026 | 1287 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2021 | 22 | 0.050 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2021 | 11 | 0.040 |
Why?
|
| RNAi Therapeutics | 1 | 2021 | 12 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2026 | 907 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2023 | 247 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2021 | 80 | 0.040 |
Why?
|
| Sheep | 1 | 2021 | 189 | 0.040 |
Why?
|
| Fibrosis | 1 | 2021 | 172 | 0.040 |
Why?
|
| Triglycerides | 1 | 2021 | 248 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 428 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 673 | 0.040 |
Why?
|
| Mannitol | 1 | 2018 | 15 | 0.040 |
Why?
|
| Propylene Glycols | 1 | 2018 | 9 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2018 | 31 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2018 | 64 | 0.030 |
Why?
|
| Aptamers, Nucleotide | 1 | 2018 | 28 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2018 | 45 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2018 | 116 | 0.030 |
Why?
|
| Astrocytes | 1 | 2018 | 123 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2017 | 30 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2024 | 710 | 0.030 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 99 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2017 | 115 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 765 | 0.030 |
Why?
|
| Cyclophilins | 1 | 2016 | 12 | 0.030 |
Why?
|
| RNA Stability | 1 | 2017 | 104 | 0.030 |
Why?
|
| COS Cells | 1 | 2016 | 180 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 243 | 0.030 |
Why?
|
| Transferrin | 1 | 2016 | 70 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 615 | 0.030 |
Why?
|
| Lipids | 1 | 2018 | 327 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 401 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 57 | 0.030 |
Why?
|
| Kidney | 1 | 2017 | 450 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 920 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1186 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 961 | 0.030 |
Why?
|
| Rats | 1 | 2018 | 1989 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 354 | 0.030 |
Why?
|
| Peptides | 1 | 2018 | 588 | 0.030 |
Why?
|
| Male | 2 | 2025 | 30957 | 0.030 |
Why?
|
| Obesity | 1 | 2021 | 1266 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2017 | 1161 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2018 | 917 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1692 | 0.020 |
Why?
|